Objective: To determine whether antibodies against Sarcocystis neurona could be detected in CSF from clinically normal neonatal (2 to 7 days old) and young (2 to 3 months old) foals.
Design: Prospective study.
Animals: 15 clinically normal neonatal Thoroughbred foals.
Procedure: Serum and CSF samples were obtained from foals at 2 to 7 days of age and tested for antibodies against S. neurona by means of western blotting. Serum samples from the mares were also tested for antibodies against S. neurona. Additional CSF and blood samples were obtained from 5 foals between 13 and 41 days after birth and between 62 and 90 days after birth.
Results: Antibodies against S. neurona were detected in serum from 13 mares and their foals; antibodies against S. neurona were detected in CSF from 12 of these 13 foals. Degree of immunoreactivity in serum and CSF decreased over time, and antibodies against S. neurona were no longer detected in CSF from 2 foals 83 and 84 days after birth. However, antibodies could still be detected in CSF from the other 3 foals between 62 and 90 days after birth.
Conclusions And Clinical Relevance: Results indicate that antibodies against S. neurona can be detected in CSF from clinically normal neonatal (2 to 7 days old) foals born to seropositive mares. This suggests that western blotting of CSF cannot be reliably used to diagnose equine protozoal myeloencephalitis in foals < 3 months of age born to seropositive mares.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2460/javma.2002.220.208 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of refrigeration, room temperature, and processing time on serum immunofluorescent antibody titers for Sarcocystis neurona.
J Vet Intern Med
December 2024
Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California Davis, Davis, California, USA.
Background: Evaluating antibody titers for Sarcocystis neurona for the diagnosis of equine protozoal myeloencephalitis from serum samples is a common practice. However, ensuring timely and proper refrigeration is not always possible.
Objectives: To evaluate immunofluorescent antibody (IFA) titers for S.
Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis.
Mult Scler
September 2024
Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Article Synopsis
- The study evaluates the effectiveness of simplified imaging methods (central vein sign or CVS) compared to cerebrospinal fluid oligoclonal bands (OCB) as diagnostic tools for multiple sclerosis (MS).
- Results indicate that both methods have similar sensitivity and specificity, with a higher positive predictive value (PPV) for the CVS method after 12 months.
- Further research is planned to determine if CVS can replace or work alongside OCB for diagnosing MS.
sp. meningoencephalitis in a captive bobcat.
J Vet Diagn Invest
November 2024
University of Tennessee College of Veterinary Medicine, Knoxville, TN, USA.
A geriatric captive bobcat () was euthanized due to progressive anorexia and lethargy. Meningoencephalitis with intralesional apicomplexan organisms was identified histologically. With immunohistochemistry, the organisms were immunolabeled by anti- antibodies.
View Article and Find Full Text PDFTranscobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.
Sci Transl Med
June 2024
Department of Neurology, University of California, San Francisco (UCSF), San Francisco, CA 94158, USA.
Article Synopsis
- Vitamin B12 is essential for blood cell formation and nerve insulation, and its deficiency can lead to neurological issues despite normal blood levels, as seen in a patient with symptoms like tremor and cognitive decline.
- Researchers discovered an autoantibody against the transcobalamin receptor (CD320) that hinders vitamin B12 uptake in the brain, resulting in low levels found in cerebrospinal fluid even when blood levels appear normal.
- The study suggests this autoimmune condition can be treated with immunosuppressive therapy and high-dose vitamin B12, and highlights the importance of recognizing how B12 transport differs in various tissues, which could improve diagnosis and treatment strategies for similar neurological disorders.
A fresh look at the SarcoFluor antibody test for the detection of specific antibodies to Sarcocystis neurona for the diagnosis of equine protozoal myeloencephalitis.
Vet Parasitol
August 2024
Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California Davis, Tupper Hall 2108, One Shields Avenue, Davis, CA 95616, USA.
Equine protozoal myeloencephalitis (EPM) is a challenging disease to diagnose in horses with neurological signs. To optimize contemporary diagnostic testing, including the use of serum:CSF antibody ratios, the SarcoFluor antibody test for Sarcocystis neurona requires revalidation. The SarcoFluor, a previously validated immunofluorescent antibody test (IFAT) for the detection of antibodies specific to S.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!